Skip to main content

Canadabis Capital Inc(CANB-X)
TSX Venture

Today's Change
Delayed Last Update
Day Low0.015
Day High0.015
Open:0.015
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Select a category then submit the form to load news
Newswire.ca
CANADABIS ANNOUNCES DELAY IN FILING OF SECOND QUARTER FINANCIAL STATEMENTS
Newswire.ca
CANADABIS CAPITAL ANNOUNCES RESULTS OF SHAREHOLDERS MEETING
Newswire.ca
CanadaBis Reports Fiscal Q1 2026 Results with Positive Operating Cash Flow
Newsfile
Updated Upcoming Meeting Dates - December 15, 2025
Newsfile
Upcoming Meeting Dates - December 15, 2025
Newswire.ca
CANADABIS CAPITAL PROPOSES REDUCTION TO CONVERTIBLE DEBENTURE CONVERSION PRICE AND ANNOUNCES INTENTION TO PAY NEXT INSTALLMENT DEBENTURE INTEREST IN COMMON SHARES
Newswire.ca
Canadabis Capital Inc. Announces 2025 Fiscal Year Financial Results
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
Newswire.ca
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Revenue Q3 F2025 Resulting in Positve Adjusted EBITDA of $440,665.00 with Gross sales of $5.5 Million as well as 6% increase in Gross Earnings over the prior periods
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (CANB)
Newswire.ca
Arrangement Agreement Between CanadaBis Capital and Simply Solventless Inc. Terminated
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (CANB)
Newswire.ca
CANADABIS ANNOUNCES CLOSING OF FINANCING
PR Newswire
CANADABIS ANNOUNCES CLOSING OF FIRST TRANCHE OF FINANCING FOR $2.6 MILLION
Newswire.ca
CANADABIS ANNOUNCES UPSIZE OF CONVERTIBLE DEBENTURE FINANCING TO $4.5 MILLION
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (CANB)
Newswire.ca
SIMPLY SOLVENTLESS ANNOUNCES HIGHLY ACCRETIVE ALL SHARE DEAL TO ACQUIRE CANADABIS (STIGMA GROW), CREATING #2 CONCENTRATES AND #5 PREROLL PRODUCER, AND CANADABIS ANNOUNCES $2.5 MILLION CONVERTIBLE DEBENTURE FINANCING
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (CANB)
PR Newswire
Canadabis Capital Celebrates Historic Milestone: First Shipment of Stigma Grow Products to Portugal
PR Newswire
CanadaBis Capital With its wholly owned Sub. (STIGMA GROW) Announces Record Revenue Q1 F2025 Resulting in $9.6M Gross with $321,569 in NET Earnings and an Adjusted EBITDA of $675,892
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Healthcare Sector Stocks on TSX-V (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Drug Manufacturers Industry Stocks (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Bottom 25 Performing Stocks Year-to-Date on TSX-V (CANB)
AI-generated - The Globe and Mail
CanadaBis Cap: Top 10 Undervalued Growth Stocks on TSX-V (CANB)

Profile

CanadaBis Capital Inc is a vertically integrated cannabis company. The firm engages in the production and sale of recreational cannabis. Its product line consists of Stigma Roots. It operates in three segments: wholesale, retail, and extract. The wholesale segment cultivates and distributes cannabis and cannabis products to and through, provincial liquor and cannabis boards. Retail segment involves sale of cannabis and cannabis-related products to end consumers on-premises owned and operated by the Company. Extract segment provides cannabinoid extraction services to other licensed producers. The company generates maximum of its revenue from Extract Segment.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.